Clinical Trial Update: SorAfenib Versus RADIOEMBOLIZATION in Advanced Hepatocellular Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Sorafenib to radioembolization in advanced hepatocellular carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Radioembolization
• Sorafenib (Sorafenib)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Liver Carcinoma | Phase 3 | Status: COMPLETED